Literature DB >> 18095233

A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.

N Papanas1, K Papatheodorou, D Papazoglou, C Monastiriotis, D Christakidis, E Maltezos.   

Abstract

UNLABELLED: Peripheral neuropathy remains a major cause of morbidity and is a cardinal factor in the pathogenesis of diabetic foot ulceration. The aim of the present study was to compare the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold (VPT) and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes. This study included 154 type 2 diabetic patients (76 men) with a mean age of 64.3+/-7.3 years and a mean diabetes duration of 12.8+/-4.3 years. Neuropathy was diagnosed clinically using the Neuropathy Disability Score (NDS). The VPT was measured with a neurothesiometer, values > 25Volts being classified as abnormal. Sudomotor function was evaluated by the indicator test. Sensitivity of the indicator test for neuropathy was 97.8% and specificity was 67.2%. Sensitivity and specificity of VPT for neuropathy were 78.9% and 85.9% respectively. A significant correlation was shown between time to colour change of the indicator test and VPT (rs=0.889, p<0.001).
CONCLUSIONS: Both the indicator test and the VPT have a high sensitivity for neuropathy. Sensitivity is higher with the indicator test, but specificity is higher with VPT. Time until complete colour change of the indicator test shows a positive correlation with VPT. Thus, the indicator test appears to be a useful additional diagnostic tool of neuropathy, particularly suitable for screening and self-examination, in type 2 diabetes. The correlation between time to colour change of the indicator test and VPT is interesting and merits investigation in a prospective study.

Entities:  

Mesh:

Year:  2007        PMID: 18095233     DOI: 10.1055/s-2007-984455

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  11 in total

Review 1.  Screening for the high-risk foot of ulceration: tests of somatic and autonomic nerve function.

Authors:  Vasiliki Argiana; Ioanna Eleftheriadou; Nicholas Tentolouris
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

2.  The diabetic foot: a global threat and a huge challenge for Greece.

Authors:  N Papanas; E Maltezos
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

3.  Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy.

Authors:  B Rodríguez-Sánchez; L M Peña-Longobardo; A J Sinclair
Journal:  Eur J Health Econ       Date:  2019-11-12

4.  Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study.

Authors:  Catherine L Martin; Barbara H Waberski; Rodica Pop-Busui; Patricia A Cleary; Sarah Catton; James W Albers; Eva L Feldman; William H Herman
Journal:  Diabetes Care       Date:  2010-09-10       Impact factor: 19.112

5.  The diagnostic accuracy of Neuropad for assessing large and small fibre diabetic neuropathy.

Authors:  G Ponirakis; I N Petropoulos; H Fadavi; U Alam; O Asghar; A Marshall; M Tavakoli; R A Malik
Journal:  Diabet Med       Date:  2014-07-14       Impact factor: 4.359

6.  Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes.

Authors:  Nikolaos Papanas; Paschalis Paschos; Dimitrios Papazoglou; Konstantinos Papatheodorou; Konstantinos Paletas; Efstratios Maltezos; Apostolos Tsapas
Journal:  Diabetes Care       Date:  2011-04-19       Impact factor: 19.112

7.  Automated Quantification of Neuropad Improves Its Diagnostic Ability in Patients with Diabetic Neuropathy.

Authors:  Georgios Ponirakis; Hassan Fadavi; Ioannis N Petropoulos; Shazli Azmi; Maryam Ferdousi; Mohammad A Dabbah; Ahmad Kheyami; Uazman Alam; Omar Asghar; Andrew Marshall; Mitra Tavakoli; Ahmed Al-Ahmar; Saad Javed; Maria Jeziorska; Rayaz A Malik
Journal:  J Diabetes Res       Date:  2015-05-12       Impact factor: 4.011

Review 8.  Recent Advances in Diagnostic Strategies for Diabetic Peripheral Neuropathy.

Authors:  Jong Chul Won; Tae Sun Park
Journal:  Endocrinol Metab (Seoul)       Date:  2016-05-27

Review 9.  New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine.

Authors:  Heng Yang; Gordon Sloan; Yingchun Ye; Shuo Wang; Bihan Duan; Solomon Tesfaye; Ling Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-17       Impact factor: 5.555

10.  Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus.

Authors:  Georgia Chatzikosma; Kalliopi Pafili; Maria Demetriou; Konstantinos Vadikolias; Efstratios Maltezos; Nikolaos Papanas
Journal:  Arch Med Sci       Date:  2016-04-12       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.